53-035
GSK 2194069
Manufacturer: Fischer Scientific
CAS Number: 1332331-08-4
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 53-035-Each-of-1 | In Stock | ₹ 19,713.50 |
53-035 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 19,713.50
GST (18%): ₹ 3,548.43
Total Price: ₹ 23,261.93
Chemical Name or Material
4-[4-(5-Benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
Assay Percent Range
>99%
Molecular Formula
C25H24N4O3
CAS
1332331-08-4
Quantity
5 mg
Formula Weight
Observed MW: 428.48
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
GSK 2194069 | -- | -- | ||
GSK 2194069 | -- | ₹ 74,226.00 | ||
Sigma Aldrich Fine Chemicals Biosciences GSK2194069 >=97% (HPLC) | 1332331-08-4 | MFCD28167807 | 25MG | -- | ₹ 87,166.60 | ||
Sigma Aldrich Fine Chemicals Biosciences GSK2194069 >=97% (HPLC) | 1332331-08-4 | MFCD28167807 | 5MG | -- | ₹ 22,568.62 | ||
1332331-08-4 | 3H-1,2,4-Triazol-3-one, 4-[4-(5-benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro- | -- | ₹ 3,916.00 - ₹ 2,20,008.00 |
Related Products
Description
- Potent human fatty acid synthase (hFASN) inhibitor (IC50 = 7.7 nM); inhibits hFAS β-ketoacyl reductase activity
- Inhibits lipid synthesis and attenuates proliferation of A549 non-small-cell lung cancer cells (EC50 = 15 nM) in vitro .
SAFETY INFORMATION
- Recommended Storage : Store at 4°C